David J. Eyerman, Ph.D.
Affiliations: | 2008 | Boston University, Boston, MA, United States |
Area:
Pharmacology, Neuroscience BiologyGoogle:
"David Eyerman"Mean distance: 19430.2
Parents
Sign in to add mentorBryan K. Yamamoto | grad student | 2008 | Boston University | |
(The role of the vesicular monoamine transporter-2 and nicotinic acetylcholine receptors in methamphetamine toxicity to the rat striatum.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cunningham JI, Todtenkopf MS, Dean RL, et al. (2021) Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats. Pharmacology, Biochemistry, and Behavior. 173157 |
Ferdousi MI, Calcagno P, Clarke M, et al. (2020) Hyporesponsivity to mu-opioid receptor agonism in the Wistar-Kyoto rat model of altered nociceptive responding associated with negative affective state. Pain |
Burke NN, Li Y, Deaver DR, et al. (2019) Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats. Journal of Psychopharmacology (Oxford, England). 269881119872203 |
Cunningham JI, Eyerman DJ, Todtenkopf MS, et al. (2019) Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates. Journal of Psychopharmacology (Oxford, England). 269881119856850 |
Cunningham J, Eyerman D, Todtenkopf M, et al. (2019) P.125 Samidorphan, an opioid receptor antagonist, mitigates olanzapine-induced metabolic dysfunction in female rats European Neuropsychopharmacology. 29: S103-S104 |
Smith K, Deaver D, Dean R, et al. (2019) Mu dependent effects of buprenorphine in combination with samidorphan on immobility behavior in Wistar Kyoto rats European Neuropsychopharmacology. 29: S63-S64 |
Cunningham J, Eyerman DJ, Todtenkopf M, et al. (2019) F160. Samidorphan, an Opioid Receptor Antagonist, Mitigates Olanzapine-Induced Metabolic Dysfunction in Female Rats Biological Psychiatry. 85: S275 |
Smith KL, Cunningham JI, Eyerman DJ, et al. (2018) Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology |
Cunningham J, Smith K, Dean R, et al. (2015) P.2.a.016 The effects of buprenorphine in combination with samidorphan on neurochemical and behavioral measures in Wistar Kyoto rats European Neuropsychopharmacology. 25: S384 |
Cunningham J, Dean R, Todtenkopf M, et al. (2014) P.3.a.009 Samidorphan attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in rats European Neuropsychopharmacology. 24: S489 |